Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Heart Left Ventricle Overload
100%
Sildenafil
100%
Diseases
100%
Hemodynamic
66%
Mitogen-Activated Protein Kinase
66%
Pulmonary Hypertension
66%
Calcineurin
66%
Phosphodiesterase V
66%
Inflammation
66%
Dexamethasone
33%
Cardiovascular Disease
33%
Heart Right Ventricle Function
33%
Left Ventricular Hypertrophy
33%
Signal Transduction
33%
Myocardium
33%
Heart Left Ventricle Failure
33%
Upregulation
33%
Heart Left Ventricle Function
33%
Vasodilatation
33%
Marker Gene
33%
Heart Ventricle Remodeling
33%
Cyclic GMP
33%
Aortic Constriction
33%
Afterload
33%
Heart Right Ventricle Pressure
33%
Phosphodiesterase V Inhibitor
33%
Cyclic GMP Phosphodiesterase
33%
Pharmacology, Toxicology and Pharmaceutical Science
Sildenafil
100%
Heart Left Ventricle Overload
100%
Diseases
100%
Inflammation
66%
Mitogen Activated Protein Kinase
66%
Pulmonary Hypertension
66%
Calcineurin
66%
Phosphodiesterase V
66%
Dexamethasone
33%
Heart Left Ventricle Failure
33%
Heart Left Ventricle Hypertrophy
33%
Cyclic GMP
33%
Phosphodiesterase V Inhibitor
33%
Heart Ventricle Remodeling
33%
Aortic Constriction
33%
Cyclic GMP Phosphodiesterase
33%
Cardiovascular Disease
33%
Keyphrases
Right Ventricular
100%
Derangement
100%
Left Ventricular Pressure Overload
100%
Sildenafil
100%
Left Ventricular Function
30%
Phosphodiesterase Type 5 Inhibitors
30%
Inflammation
20%
Hemodynamic Changes
20%
Extracellular Signal-regulated Kinase
20%
Molecular Changes
20%
Calcineurin
20%
Right Heart Hemodynamics
20%
Left Ventricular Disease
20%
Disease Stage
10%
Right Ventricular Function
10%
Therapeutic Strategies
10%
Hypertrophy
10%
Left Ventricular Hypertrophy
10%
Signaling Pathway
10%
Poor Prognosis
10%
Left Ventricular Dysfunction
10%
Molecular Features
10%
Myocardium
10%
Heart Disease
10%
Pulmonary Hypertension
10%
Molecular Alterations
10%
Impaired Left Ventricular Function
10%
Gene Markers
10%
Transverse Aortic Constriction
10%
Afterload
10%
Right Ventricular Systolic Pressure
10%
Right Ventricular Free Wall
10%
Pressure Function
10%
Vasorelaxation
10%
Molecular Crosstalk
10%
Left Ventricular Support
10%
Right Ventricular Remodeling
10%
Secondary Pulmonary Hypertension
10%
Cyclic Guanosine Monophosphate Signaling
10%
Interventricular Interaction
10%
Cyclic Guanosine Monophosphate Phosphodiesterase
10%